↓ Skip to main content

Cochrane Database of Systematic Reviews

Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses

Overview of attention for article published in Cochrane database of systematic reviews, April 2005
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
222 Mendeley
Title
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses
Published in
Cochrane database of systematic reviews, April 2005
DOI 10.1002/14651858.cd003729.pub2
Pubmed ID
Authors

Ravindra B Belgamwar, Mark Fenton

Abstract

People presenting with agitated or violent behaviour thought to be due to severe mental illness may require urgent pharmacological tranquillisation. Several preparations of olanzapine, an antipsychotic drug, are now being used for management of such agitation.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 222 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 <1%
Israel 1 <1%
Netherlands 1 <1%
Canada 1 <1%
United Kingdom 1 <1%
Unknown 216 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 15%
Student > Master 32 14%
Student > Bachelor 30 14%
Student > Ph. D. Student 23 10%
Other 19 9%
Other 38 17%
Unknown 47 21%
Readers by discipline Count As %
Medicine and Dentistry 81 36%
Psychology 32 14%
Nursing and Health Professions 14 6%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Social Sciences 8 4%
Other 24 11%
Unknown 53 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2017.
All research outputs
#11,709,879
of 20,852,059 outputs
Outputs from Cochrane database of systematic reviews
#9,496
of 12,059 outputs
Outputs of similar age
#88,606
of 184,134 outputs
Outputs of similar age from Cochrane database of systematic reviews
#72
of 105 outputs
Altmetric has tracked 20,852,059 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,059 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.5. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,134 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.